Correlation Between Rush Street and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rush Street and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rush Street and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rush Street Interactive and Moleculin Biotech, you can compare the effects of market volatilities on Rush Street and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rush Street with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rush Street and Moleculin Biotech.

Diversification Opportunities for Rush Street and Moleculin Biotech

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Rush and Moleculin is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Rush Street Interactive and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Rush Street is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rush Street Interactive are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Rush Street i.e., Rush Street and Moleculin Biotech go up and down completely randomly.

Pair Corralation between Rush Street and Moleculin Biotech

Considering the 90-day investment horizon Rush Street Interactive is expected to generate 0.56 times more return on investment than Moleculin Biotech. However, Rush Street Interactive is 1.77 times less risky than Moleculin Biotech. It trades about 0.29 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.08 per unit of risk. If you would invest  1,058  in Rush Street Interactive on August 25, 2024 and sell it today you would earn a total of  274.00  from holding Rush Street Interactive or generate 25.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Rush Street Interactive  vs.  Moleculin Biotech

 Performance 
       Timeline  
Rush Street Interactive 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Rush Street Interactive are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Rush Street demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Moleculin Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Rush Street and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rush Street and Moleculin Biotech

The main advantage of trading using opposite Rush Street and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rush Street position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.
The idea behind Rush Street Interactive and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm